{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:29:54Z","timestamp":1774121394083,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T00:00:00Z","timestamp":1248393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The anti\u2010inflammatory effects of CI\u20101044 and of the other selective PDE4 inhibitors rolipram and cilomilast were investigated in Brown\u2010Norway (BN) rats, against lipopolysaccharide\u2010induced tumor necrosis factor \u03b1 (TNF\u03b1) production in whole blood and antigen\u2010induced lung eosinophilia. In vitro, CI\u20101044 inhibited TNF\u03b1 production with an IC<jats:sub>50<\/jats:sub>of 0.31\u2003\u03bc<jats:sc>m<\/jats:sc>being equipotent to Cilomilast (IC<jats:sub>50<\/jats:sub>\u2003=\u20030.26\u2003\u03bc<jats:sc>m<\/jats:sc>) and rolipram (IC<jats:sub>50<\/jats:sub>\u2003=\u20030.11\u2003\u03bc<jats:sc>m<\/jats:sc>). Given orally, CI\u20101044 inhibited ex vivo TNF\u03b1 production with an ED<jats:sub>50<\/jats:sub>value of 0.4\u2003mg\/kg after single administration, whereas rolipram (ED<jats:sub>50<\/jats:sub>\u2003=\u20031.4\u2003mg\/kg) and cilomilast (ED<jats:sub>50<\/jats:sub>\u2003=\u20031.6\u2003mg\/kg) were less potent. In the same ex vivo setting, but given repeatedly, CI\u20101044 led to an ED<jats:sub>50<\/jats:sub>of 0.5\u2003mg\/kg corresponding to a plasma concentration of 82.6\u2003ng\/mL (0.22\u2003\u03bc<jats:sc>m<\/jats:sc>). In vivo, CI\u20101044 prevented TNF\u03b1 release with an ED<jats:sub>50<\/jats:sub>of 1\u2003mg\/kg p.o. and inhibited ovalbumin\u2010induced lung eosinophilia following single or repeated oral administration with an ED<jats:sub>50<\/jats:sub>of 3.25 and 4.8\u2003mg\/kg p.o., respectively, suggesting the absence of pharmacological tolerance. CI\u20101044 in this model was equipotent to rolipram (81% inhibition at 10\u2003mg\/kg) but better than cilomilast (25% inhibition at 10\u2003mg\/kg). Finally, CI\u20101044 (10\u2003mg\/kg) inhibited inflammatory cell recruitment with a long duration of action (up to 8\u2003h) and was still active when given post\u2010challenge. Our data show that CI\u20101044 is an orally active PDE4 inhibitor that may be used as an anti\u2010inflammatory therapy in lung inflammatory diseases.<\/jats:p>","DOI":"10.1111\/j.1472-8206.2009.00725.x","type":"journal-article","created":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T07:14:34Z","timestamp":1248419674000},"page":"73-82","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Relationship between phosphodiesterase type 4 inhibition and anti\u2010inflammatory activity of CI\u20101044 in rat airways"],"prefix":"10.1111","volume":"24","author":[{"given":"Marie\u2010Pierre","family":"Pruniaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Lagente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malika","family":"Ouaged","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Julien\u2010Larose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie\u2010Noelle","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Leportier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Bouget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Pierre","family":"Dubuit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Burnouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette M.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude P.","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.2.9708012"},{"key":"e_1_2_6_3_2","article-title":"Mammalian cyclic nucleotide phosphodiesterases and their cDNA sequences","author":"Lanfear J.","year":"1999","journal-title":"Eur. Pat. Appl."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612023394665"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.307"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.95.08030457"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.12.059"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36130"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059020-00004"},{"key":"e_1_2_6_10_2","first-page":"A505","article-title":"Cilomilast efficacy in a 12\u2010month study of patient with asthma","volume":"161","author":"Compton C.H.","year":"2000","journal-title":"Am. J. Resp. Crit. Care Med."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05481-2"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/00912700222011328"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67100-0"},{"key":"e_1_2_6_14_2","first-page":"69","article-title":"Assay of nucleotide phosphodiesterase and resolution of multiple molecular forms of the isoenzyme","volume":"10","author":"Thompson J.W.","year":"1979","journal-title":"Adv. Cycl. Nucleotide Res."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00778a018"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90694-1"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01793218"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.10.6.2678"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(94)90155-4"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490410204"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm000315p"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3565(24)37221-0","article-title":"SB 207499 (Cilomilast), a potent and selective second\u2010generation phosphodiesterase 4 inhibitor: in vitro anti\u2010inflammatory actions","volume":"284","author":"Barnette M.S.","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0192-0561(94)90054-X"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-3565(24)36487-0","article-title":"The phosphodiesterase type 4 (PDE4) inhibitor CP\u201080,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor\u2010\u03b1 (TNF\u03b1) production in mice: effect of adrenalectomy","volume":"280","author":"Cheng J.B.","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702387"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0022-3565(25)10457-6","article-title":"Stimulation of beta\u2010adrenoceptors in a human monocyte cell line (U937) upregulates cyclic AMP (specific phosphodiesterase activity","volume":"263","author":"Torphy T.J.","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3565(24)37847-4","article-title":"SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin\u20104 production in vivo","volume":"287","author":"Griswold D.E.","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.2009.00725.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.2009.00725.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T10:58:04Z","timestamp":1739271484000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.2009.00725.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,4]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1472-8206.2009.00725.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.2009.00725.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,4]]},"assertion":[{"value":"2010-01-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}